New DrugDev Educational Webinar Details how Pharma Can Improve Protocol Adherence and Data Management with Site Engagement Technology
Philadelphia PA and London UK – Subject matter experts from DrugDev, an IQVIA company, will share best practices for clinical trial protocol adherence and data management with site engagement technology in an educational webinar February 8, 9am EST/2pm GMT.
According to a study published in the September 2016 Journal of Clinical Pharmacology, not adhering to a clinical study protocol can increase variance, lower study power and reduce the magnitude of treatment effects. Inappropriate subjects, such as patients who do not have the illness, do not report exclusionary conditions, falsify medication adherence, or are taking part in concurrent trials can muddle safety and efficacy signals.
Webinar: Improving Protocol Adherence Using Site Engagement Technology
Date: Thursday, February 8, 2018
Time: 9am EST | 2pm GMT
Presenters: Lesley Freese, DrugDev Senior Manager, Operations; and Dani Darasz, DrugDev Associate Director, Professional Services
With sites focused on activities including patient enrollment, visits and adherence it is of vital importance that sponsors do everything they can to streamline trials. At this webinar attendees will learn the negative impacts of mismanaging protocol adherence and data management. The presenters also will discuss best practices for using site engagement to improve protocol adherence and data management while making life as easy as possible for sites.
About the Presenters:
- Lesley Freese, DrugDev Senior Manager, Operations – With over 13 years of experience, Freese is a subject matter expert in the site engagement and site activation space. She spent many years running clinical trials at the site level before joining DrugDev to lead project management teams implementing DrugDev Spark™ technology.
- Dani Darasz, DrugDev Associate Director, Professional Services – Darasz has over 10 years of experience in the healthcare and pharmaceutical industries. Having spent some of her career at a clinical site, Dani leverages her site experience while leading the design and execution of DrugDev Spark(tm) technology.
DrugDev, an IQVIA company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on over 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.